XXXX and bone mineral density in renal transplantation.

@entity1 @entity6685 @entity6 @entity174 @entity1337 @entity170 @entity2331 @entity158 @entity1011 @entity461
INTRODUCTION: The reduction of bone mineral density (BMD) levels is an important complication after renal transplantation. The prevalence of nontraumatic lesions may reach 22%. @entity1 with lower osseous mass suffer the highest number of lesions. OBJECTIVE: Evaluate BMD in @entity1 over 30-years old who have undergone renal transplantation more than 1 year prior, who attend a medical facility complaining of @entity158 and were prescribed rest or any @entity1337 . @entity1 AND METHODS: One hundred twenty-three @entity1 who received a renal transplant from a cadaveric donor from 1980 through 2000 were included in the present study to measure BMD levels in the hips and the vertebral column using a densitometer (Hologic 4500 QDR). Our study complied with WHO recommendations, which define normal values as a T score >-1 SD @entity2331 as a (T score between <-1 and >-2.5 SD), and @entity170 as a T score <-2.5 SD. @entity1 were divided into three groups according to gender and hormonal status. The following clinical and analytic data were collected: age, gender, race, age at onset of menopause, @entity6 ( @entity6 ), weight, size, retransplantation, period of evolution after transplantation, and @entity6685 ( @entity461 ), @entity1011 , and renal clearance values. RESULTS: There were 51 @entity1 (41.1%) included. Forty postmenopausal (32.5%) and premenopausal @entity1 (26%) were also included. In all @entity1 we observed a correlation between a reduction in BMD values and age, duration post-transplantation, and body weight (P<.05). Reduced BMD levels in premenopausal @entity1 were related with lower body weight, (P<.05) and elevated @entity461 levels (P<.024). CONCLUSIONS: We observed that @entity1 who had undergone transplantation displayed a moderately higher risk of suffering a @entity174 . Such risk increased in the case of @entity1 with more frequent fractures in the vertebral column. In 23.8% of @entity1 reporting @entity158 , there was no reduction in BMD levels. Therefore, we must look for other disorder, responsible for the @entity158 and prescribe adequate treatment.
